The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis

References

• Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013;17:R168. doi:10.1186/cc1273423899120
   PubMed Web of Science ®Google Scholar
• Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5:16–19. doi:10.5847/wjem.j.1920-8642.2014.01.00225215141
   PubMedGoogle Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–810. doi:10.1001/jama.2016.028726903338
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu D, Liu YN, et al. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care. 2015;19:323. doi:10.1186/s13054-015-1032-426357898
   PubMed Web of Science ®Google Scholar
• Heublein S, Hartmann S, Hagel S, et al. Epidemiology of sepsis in German hospitals derived from administrative databases. Infection. 2013;41:S71.
   Web of Science ®Google Scholar
• Escarce JJ, Kelley MA. Admission source to the medical intensive care unit predicts hospital death independent of APACHE II score. J Am Med Assoc. 1990;264:2389–2394. doi:10.1001/jama.1990.03450180053028
   PubMed Web of Science ®Google Scholar
• Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. J Am Med Assoc. 2001;286:1754–1758. doi:10.1001/jama.286.14.1754
   PubMed Web of Science ®Google Scholar
• Vincent JL, Opal SM, Marshall JC. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med. 2010;38:283–287. doi:10.1097/CCM.0b013e3181b785a219730252
   PubMed Web of Science ®Google Scholar
• Lee YT, Gong M, Chau A, et al. Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis. J Infect. 2018;76:1–10. doi:10.1016/j.jinf.2017.10.01629174966
   PubMed Web of Science ®Google Scholar
• Enguix-Armada A, Escobar-Conesa R, Garcia-De La Torre A, et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2016;54:163–168. doi:10.1515/cclm-2015-024326083268
   PubMed Web of Science ®Google Scholar
• Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15. doi:10.1186/cc887220144219
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang F, Fan X, et al. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 2012;16:R229. doi:10.1186/cc1188423194114
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–217. doi:10.1086/42199715307030
   PubMed Web of Science ®Google Scholar
• Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med Hypotheses. 2001;164:396–402. doi:10.1164/ajrccm.164.3.2009052
   PubMed Web of Science ®Google Scholar
• Arora S, Singh P, Singh PM, et al. Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis. Shock. 2015;43:212–221. doi:10.1097/SHK.000000000000030525423128
   PubMed Web of Science ®Google Scholar
• Liu D, Su L, Han G, et al. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS One. 2015;10:e0129450. doi:10.1371/journal.pone.012945026076027
   PubMed Web of Science ®Google Scholar
• Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764–769. doi:10.1007/s10156-010-0197-721560033
   PubMed Web of Science ®Google Scholar
• Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412:157–161. doi:10.1016/j.cca.2011.07.024
   Web of Science ®Google Scholar
• Shirakawa K, Naitou K, Hirose J, et al. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med. 2011;49:937–939. doi:10.1515/CCLM.2011.06621345045
   PubMed Web of Science ®Google Scholar
• Sugie Y, Igami K, Shoji K, et al. Performance evaluation of the new rapid fertility assays in whole blood and plasma on PATHFAST. Clin Lab. 2011;57:99–106.21391473
   PubMed Web of Science ®Google Scholar
• Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11:234–238. doi:10.1007/s10156-005-0400-416258819
   PubMedGoogle Scholar
• Brodska H, Valenta J, Pelinkova K, et al. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome. Clin Chem Lab Med. 2017;56:658–668.
   Web of Science ®Google Scholar
• de la Torre-Prados MV, García-de la Torre A, Escobar-Conesa R, et al. Accuracy prognostic using presepsin and proadrenomedullin in critically septic patients. Intensive Care Med. 2014;40(1 SUPPL. 1):S210.
   Google Scholar
• Yang HS, Hur M, Yi A, et al. Prognostic value of presepsin in adult patients with sepsis: systematic review and meta-analysis. PLoS One. 2018;13:e0191486. doi:10.1371/journal.pone.019148629364941
   PubMed Web of Science ®Google Scholar
• Spanuth E, Ebeit H, Ivandic B, et al. Diagnostic and prognostic value of soluble CD14 subtype (sCD14-ST) in emergency patients with early sepsis using the new assay pat HFAST presepsin. Clin Chem Lab Med. 2011;49(1):S361. doi:10.1515/CCLM.2011.066
   Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530–538. doi:10.1007/s00134-003-1662-x12664219
   PubMedGoogle Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care. 1992;20:864–874. doi:10.1097/00003246-199206000-00025
   Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013;41:580–637. doi:10.1097/CCM.0b013e31829133d623353941
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. Thedevelopment of QUADAS: a tool for the quality assessment ofstudies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. doi:10.1186/1471-2288-3-2514606960
   PubMedGoogle Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. doi:10.2307/2529310843571
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558. doi:10.1002/sim.118612111919
   PubMed Web of Science ®Google Scholar
• Fagan TJ. Letter: nomogram for Bayes theorem. N Engl J Med. 1975;293:257. doi:10.1056/NEJM1975073129305131143310
   PubMed Web of Science ®Google Scholar
• Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care. 2014;18:R6. doi:10.1186/cc1371224393424
   PubMed Web of Science ®Google Scholar
• Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care. 2017;7:27. doi:10.1186/s13613-017-0252-y28271449
   PubMed Web of Science ®Google Scholar
• El-Shafie ME-S, Taema KM, El-Hallag MM, et al. Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication. Egypt J Crit Care Med. 2017;5:1–12. doi:10.1016/j.ejccm.2017.02.001
   Web of Science ®Google Scholar
• Ali FT, Ali MA, Elnakeeb MM, et al. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis. Clin Chim Acta. 2016;460:93–101. doi:10.1016/j.cca.2016.06.03027353646
   PubMed Web of Science ®Google Scholar
• Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17:R244. doi:10.1186/cc1273424138799
   PubMed Web of Science ®Google Scholar
• Carpio R, Zapata J, Spanuth E, et al. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Clin Chim Acta. 2015;450:169–175. doi:10.1016/j.cca.2015.08.01326296897
   PubMed Web of Science ®Google Scholar
• Matera G, Quirino A, Peronace C, et al. Soluble CD14 subtype-a new biomarker in predicting the outcome of critically Ill septic patients. Am J Med Sci. 2017;353:543–551. doi:10.1016/j.amjms.2017.03.03628641717
   PubMed Web of Science ®Google Scholar
• Spanuth E, Ebelt H, Ivandic B, et al. Diagnostic and prognostic value of soluble CD14 subtype (sCD14-ST) in emergency patients with early sepsis using the new assay pat HFAST presepsin. Clin Chem Lab Med. 2011;49(SUPPL. 1):S361. doi:10.1515/CCLM.2011.066
   Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554. doi:10.1056/NEJMicm02003712700374
   PubMed Web of Science ®Google Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med. 2001;29:1303–1310. doi:10.1097/00003246-200107000-0000211445675
   PubMed Web of Science ®Google Scholar
• Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66:ii33–ii40.21398306
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis. 2007;7:210–217. doi:10.1016/S1473-3099(07)70052-X17317602
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426–435. doi:10.1016/S1473-3099(12)70323-723375419
   PubMed Web of Science ®Google Scholar
• Song X, Song Y, Yuan Y, et al. Prognostic value of presepsin for outcomes and complications in enterocutaneous fistula complicated by abdominal sepsis. Int J Surg. 2016;33(Pt A):96–101. doi:10.1016/j.ijsu.2016.07.07027494999
   PubMed Web of Science ®Google Scholar
• Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008;52:48–58 e42. doi:10.1016/j.annemergmed.2008.01.00318342993
   PubMed Web of Science ®Google Scholar
• Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 2008;31:349–355. doi:10.1183/09031936.0005450717959641
   PubMed Web of Science ®Google Scholar
• Park JH, Wee JH, Choi SP, et al. The value of procalcitonin level in community-acquired pneumonia in the ED. Am J Emerg Med. 2012;30:1248–1254. doi:10.1016/j.ajem.2011.08.00922030193
   PubMed Web of Science ®Google Scholar
• Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock–a systematic review and meta-analysis. Crit Care. 2013;17:R291. doi:10.1186/cc1273424330744
   PubMed Web of Science ®Google Scholar
• Ruiz-Alvarez MJ, García-Valdecasas S, de Pablo R, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med. 2009;24:63–71. doi:10.1177/088506660832709519054806
   PubMedGoogle Scholar
• Tong X, Cao Y, Yu M, et al. Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis. Ther Clin Risk Manag. 2015;11:1027–1033. doi:10.2147/TCRM.S8481126170681
   PubMed Web of Science ®Google Scholar
• Wu J, Hu L, Zhang G, et al. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS One. 2015;10:e0133057. doi:10.1371/journal.pone.013305726192602
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu ZD, Song J, et al. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e2158. doi:10.1097/MD.000000000000087426632748
   PubMed Web of Science ®Google Scholar
• Zheng Z, Jiang L, Ye L, et al. The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis. Ann Intensive Care. 2015;5:48. doi:10.1186/s13613-015-0089-126642970
   PubMed Web of Science ®Google Scholar
• Liu Y, Hou JH, Li Q, et al. Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis. Springerplus. 2016;5:2091. doi:10.1186/s40064-016-3591-528028489
   PubMedGoogle Scholar
• Hayashida K, Kondo Y, Hara Y, et al. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7:e014305. doi:10.1136/bmjopen-2016-014305
   PubMed Web of Science ®Google Scholar
• Wu CC, Lan HM, Han ST, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017;7:91. doi:10.1186/s13613-017-0316-z28875483
   PubMed Web of Science ®Google Scholar
• Romualdo LG, Torrella PE, González MV, et al. Diagnostic accuracy of presepsin(solubleCD14subtype)for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014;47:S505–S508. doi:10.1016/j.clinbiochem.2014.02.011
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ishikura H, Nishida T, et al. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiol. 2014;14:88. doi:10.1186/1471-2253-14-8825309126
   PubMed Web of Science ®Google Scholar